Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study

Acute myeloid leukemia with t(6;9)(p22;q34) is a distinct entity accounting for 1-2% of acute myeloid leukemia cases. A substantial proportion of these patients have a concomitant FLT3-ITD. While outcomes are dismal with intensive chemotherapy, limited evidence suggests allogeneic hematopoietic cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kayser, Sabine (VerfasserIn) , Krämer, Alwin (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schlenk, Richard Friedrich (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Haematologica
Year: 2020, Jahrgang: 105, Heft: 1, Pages: 161-169
ISSN:1592-8721
DOI:10.3324/haematol.2018.208678
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2018.208678
Verlag, kostenfrei, Volltext: http://www.haematologica.org/content/early/2019/04/15/haematol.2018.208678
Volltext
Verfasserangaben:Sabine Kayser, Robert K. Hills, Marlise R. Luskin, Andrew M. Brunner, Christine Terré, Jörg Westermann, Kamal Menghrajani, Carole Shaw, Maria R. Baer, Michelle A. Elliott, Alexander E. Perl, Zdeněk Ráčil, Jiri Mayer, Pavel Zak, Tomas Szotkowski, Stéphane de Botton, David Grimwade, Karin Mayer, Roland B. Walter, Alwin Krämer, Alan K. Burnett, Anthony D. Ho, Uwe Platzbecker, Christian Thiede, Gerhard Ehninger, Richard M. Stone, Christoph Röllig, Martin S. Tallman, Elihu H. Estey, Carsten Müller-Tidow, Nigel H. Russell, Richard F. Schlenk, and Mark J. Levis

MARC

LEADER 00000caa a2200000 c 4500
001 1684116295
003 DE-627
005 20250916104101.0
007 cr uuu---uuuuu
008 191203s2020 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2018.208678  |2 doi 
035 |a (DE-627)1684116295 
035 |a (DE-599)KXP1684116295 
035 |a (OCoLC)1264253987 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kayser, Sabine  |d 1979-  |e VerfasserIn  |0 (DE-588)138694923  |0 (DE-627)605256233  |0 (DE-576)30778813X  |4 aut 
245 1 0 |a Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study  |c Sabine Kayser, Robert K. Hills, Marlise R. Luskin, Andrew M. Brunner, Christine Terré, Jörg Westermann, Kamal Menghrajani, Carole Shaw, Maria R. Baer, Michelle A. Elliott, Alexander E. Perl, Zdeněk Ráčil, Jiri Mayer, Pavel Zak, Tomas Szotkowski, Stéphane de Botton, David Grimwade, Karin Mayer, Roland B. Walter, Alwin Krämer, Alan K. Burnett, Anthony D. Ho, Uwe Platzbecker, Christian Thiede, Gerhard Ehninger, Richard M. Stone, Christoph Röllig, Martin S. Tallman, Elihu H. Estey, Carsten Müller-Tidow, Nigel H. Russell, Richard F. Schlenk, and Mark J. Levis 
264 1 |c 2020 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Pre-published: April 19, 2019 
500 |a Gesehen am 27.01.2020 
520 |a Acute myeloid leukemia with t(6;9)(p22;q34) is a distinct entity accounting for 1-2% of acute myeloid leukemia cases. A substantial proportion of these patients have a concomitant FLT3-ITD. While outcomes are dismal with intensive chemotherapy, limited evidence suggests allogeneic hematopoietic cell transplantation may improve survival if applied early during first complete remission. We report on a cohort of 178 patients with t(6;9)(p22;q34) within an international, multicenter collaboration. Median age was 46 (range: 16-76) years, acute myeloid leukemia was de novo in 88%, FLT3-ITD was present in 62%, and additional cytogenetic abnormalities in 21%. Complete remission was achieved in 81% (n=144), including 14 patients who received high-dose cytarabine after initial induction failure. With a median follow-up of 5.43 years, estimated overall survival at 5 years was 38% (95%-CI, 31-47%). Allogeneic hematopoietic cell transplantation was performed in 117 (66%) patients, including 89 in first complete remission. Allogeneic hematopoietic cell transplantation in first complete remission was associated with higher 5-year relapse-free and overall survival as compared to consolidation chemotherapy (45% [95%-CI, 35-59%] and 53% [95%-CI, 42-66%], vs. 7% [95%-CI, 3-19%] and 23% [95%-CI, 13-38%]. For patients undergoing allogeneic hematopoietic cell transplantation, overall survival rates at 5 years did not differ whether performed in first (53% [95%-CI, 42-66%]), or second complete remission (58% [95%-CI, 31-100%]; n=10) or with active disease/relapse (54% [95%-CI, 34-84%]; n=18) (P=0.67). Neither FLT3-ITD nor additional chromosomal abnormalities impacted survival. In conclusion, outcomes of t(6;9)(p22;q34) acute myeloid leukemias are poor with chemotherapy, and can be substantially improved with allogeneic hematopoietic cell transplantation. 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 105(2020), 1, Seite 161-169  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study 
773 1 8 |g volume:105  |g year:2020  |g number:1  |g pages:161-169  |g extent:9  |a Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study 
856 4 0 |u https://doi.org/10.3324/haematol.2018.208678  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.haematologica.org/content/early/2019/04/15/haematol.2018.208678  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20191203 
993 |a Article 
994 |a 2020 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 32 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 30 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 22 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 20 
998 |g 138694923  |a Kayser, Sabine  |m 138694923:Kayser, Sabine  |d 50000  |d 60000  |d 63500  |e 50000PK138694923  |e 60000PK138694923  |e 63500PK138694923  |k 0/50000/  |k 0/60000/  |k 1/60000/63500/  |p 1  |x j 
999 |a KXP-PPN1684116295  |e 3556035278 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"recId":"1684116295","person":[{"role":"aut","given":"Sabine","family":"Kayser","display":"Kayser, Sabine"},{"display":"Krämer, Alwin","family":"Krämer","role":"aut","given":"Alwin"},{"display":"Ho, Anthony Dick","family":"Ho","given":"Anthony Dick","role":"aut"},{"display":"Müller-Tidow, Carsten","role":"aut","given":"Carsten","family":"Müller-Tidow"},{"family":"Schlenk","role":"aut","given":"Richard Friedrich","display":"Schlenk, Richard Friedrich"}],"relHost":[{"id":{"zdb":["2805244-4"],"eki":["814204899"],"issn":["1592-8721"]},"part":{"text":"105(2020), 1, Seite 161-169","extent":"9","issue":"1","pages":"161-169","volume":"105","year":"2020"},"pubHistory":["99.2014 -"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"disp":"Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative studyHaematologica","physDesc":[{"extent":"Online-Ressource"}],"recId":"814204899","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 27.05.2022"],"title":[{"subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica","title_sort":"Haematologica"}],"origin":[{"dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation"}]}],"origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020"}],"note":["Pre-published: April 19, 2019","Gesehen am 27.01.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study","title_sort":"Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia - results from an international collaborative study"}],"name":{"displayForm":["Sabine Kayser, Robert K. Hills, Marlise R. Luskin, Andrew M. Brunner, Christine Terré, Jörg Westermann, Kamal Menghrajani, Carole Shaw, Maria R. Baer, Michelle A. Elliott, Alexander E. Perl, Zdeněk Ráčil, Jiri Mayer, Pavel Zak, Tomas Szotkowski, Stéphane de Botton, David Grimwade, Karin Mayer, Roland B. Walter, Alwin Krämer, Alan K. Burnett, Anthony D. Ho, Uwe Platzbecker, Christian Thiede, Gerhard Ehninger, Richard M. Stone, Christoph Röllig, Martin S. Tallman, Elihu H. Estey, Carsten Müller-Tidow, Nigel H. Russell, Richard F. Schlenk, and Mark J. Levis"]},"id":{"eki":["1684116295"],"doi":["10.3324/haematol.2018.208678"]}} 
SRT |a KAYSERSABIALLOGENEIC2020